Beste Magenkrebs Onkologen - TOP-137 Ärzte

• Surgical treatment: laparoscopic operations to remove all types of hernias (inguinal hernias, femoral hernias, umbilical hernias, postoperative ventral hernias, esophageal opening of the diaphragm and other types of abdominal wall hernias).

• Treatment of gallstone disease, removal of the gallbladder (cholecystectomy), stones in the ducts.

• Operative treatment for acute conditions (acute appendicitis, acute cholecystitis, perforating ulcer, perforation of a diverticulum, intestinal obstruction, purulent-septic diseases), all conditions of "acute abdomen".

• Treatment of oncological diseases of the stomach, intestines and other organs of the abdominal cavity and retroperitoneal space.

• Treatment of varicose veins of the legs.

• Operative treatment of obesity (bariatric surgery) and metabolic dysfunction.

• Colitis, hemorrhoids, anal itching, fissures, constipation and diarrhea, anal sphincter weakness, anal sphincter incontinence due to rupture of the perineum after childbirth.

• Abdominal injuries.

• Perianal condylomas.

• Polypos.

• Proctitis, paraproctitis and others.

Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.

He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977. 

In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa. 

Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University. 

Current Positions: 

• .Since 1997, he is the Director of the Department of Medical Oncology and Haematology, at Istituto Clinico Humanitas, Milan. Also, he is Member of the Ethics Committee of Istituto Clinico Humanitas and Director of Clinical Research in the same Institute since 2007.
• - Since 2008, he is Member of the Planning Committee, Ministry of Work and of Health and Social Politics, Rome, Italy.
• - Since October 2008, Professor Santoro is Counsellor of the Board of Directors of the Fondazione Humanitas for Research of Rozzano, Italy.
• - Since November 2008, he is Expert Member of the National Centre for the Prevention and Control of Disease, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, he is National Representative preparatory actions for the "European Partnership for Action against Cancer" Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, Professor Santoro is member of National Italian Committee on the Research Network in Oncology, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since May 2009, he is Coordinator of the Oesophageal-Stomach Cancer Group Coordinator of the Liver and Biliary Tree Cancer Group, Regional Oncology Commission – Lombardy Oncology Network.

In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009). 

Publications: santoro%a - Search Results - PubMed (nih.gov) 

Onkologe

Bauchchirurg

Leiter der Abteilung Innere Medizin, Gastroenterologe

Chefonkologe, Spezialist für die Behandlung von Tumoren der verschiedenen Lokalisationen

Dr. Ulrich Theodor Hopt ist Professor für Chirurgie und Spezialist für Pankreaschirurgie, hepatobiliäre Chirurgie, Pankreas-/Inselzelltransplantation, Ischämie-Reperfusion und onkologische Chirurgie. Er war von 2001 bis 2016 Direktor der Abteilung für Allgemein- und Viszeralchirurgie der Chirurgischen Universitätsklinik Freiburg und erhielt zahlreiche Ehrungen, darunter 1984 den Ludwig-Rehn-Preis, 1995 den Ausstellungspreis der Deutschen Gesellschaft für Chirurgie, 1998 den Prof. hc von der Capital University Peking und den Erich-Lexer-Preis 2001 der Deutschen Gesellschaft für Chirurgie.

Direktor der Abteilung für Nuklearmedizin

Dr. Friedemann Schad ist Facharzt für Innere Medizin und Gastroenterologie und Leiter des Onkologischen Zentrums am Gemeinschaftskrankenhaus Havelhöhe in Berlin, Deutschland. Er ist außerdem Mitglied der Geschäftsführung des Gemeinschaftskrankenhauses Havelhöhe, des Forschungsinstituts Havelhöhe, Berlin, des Netzwerks Onkologie, des Tumorzentrums Berlin und des Tumorzentrums gemeinnütziger & konfesioneller Krankenhäuser in Berlin eV

Onkochirurg, Spezialist für die Behandlung des Magen-Darm-Traktes

Chefarzt des Helios Klinikums Berlin-Buch, Leiter der Abteilung Onkologie und Palliativmedizin, Facharzt für Strahlentherapie.

Onkochirurg

Dr. Douglas Zippel ist leitender chirurgischer Onkologe in der Abteilung für onkologische Melanome des Assuta-Krankenhauses. Er ist ein führender chirurgischer Onkologe in der Abteilung für onkologische Melanome des Assuta-Krankenhauses. das Sheba Medical Center (Tel Hashomer) in der chirurgischen Behandlung von Melanomen und Brustkrebs. Er ist Professor für Chirurgie an der Universität Tel Aviv.

Scholoch Witali Nikolajewitsch

29.11.1980

Fachgebiet: Chirurg, Onkochirurg

Aktivitäten:

- alle Arten von offenen chirurgischen Eingriffen an den Bauchorganen

Hohlräume.

- alle Arten von laparoskopischen (endoskopischen) Eingriffen an Organen

Bauchhöhle.

- minimal-invasive Phlebologie (endovöse Laserkoagulation,

Sklerotherapie, Miniphlebektomie).

- routinemäßige und minimal-invasive (Laser-)Proktologie.

Erfahrung: 16 Jahre

1998 - 2004 – Studium an der medizinischen Fakultät von Odessa

staatliche medizinische universität.

2004 - 2006 - Praktikum in der Chirurgie.

2007 - 2018 - Einwohner der chirurgischen Abteilung Nr. 1 von Odessa

Eisenbahnkrankenhaus.

2017 - 2018 - Assistent der Abteilung für Chirurgie Nr. 1 im Odessa National

Medizinische Universität.

2018 - 2021 – Bewohner der Abteilung für chirurgisches Profil TOV

"Kardika Assistenten" (St. Catherine's Clinic).

2021 – Assistenzärztin der Abteilung für chirurgisches Profil der OMD-Klinik.

Ab 2020 - Berater mehrerer privater medizinischer Zentren.

Mitglied der Odessa Association of Surgeons

Mitglied der European Association of Endoscopic Surgeons (EAST)